Commonwealth Equity Services’s Kite Pharma, Inc. KITE Stock Holding History

Commonwealth Equity Services’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-1,586	Closed	-$285K	–	2763
2017 Q3	$285K	Sell	1,586 -1,525	-49%	-$212K	﹤0.01%	2020
2017 Q2	$323K	Sell	3,111 -1,128	-27%	-$92K	﹤0.01%	1865
2017 Q1	$333K	Buy	+4,239	New	+$262K	﹤0.01%	1781
2015 Q3	–	Sell	-3,907	Closed	-$238K	–	2273
2015 Q2	$238K	Buy	+3,907	New	+$223K	﹤0.01%	1805

Commonwealth Equity Services's KITE Position: Q4 2017 in Review

Commonwealth Equity Services sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 1,586 shares — an estimated $285K sold.

Commonwealth Equity Services first reported a position in KITE in Q2 2015 and held it in 4 quarters. The position peaked at $333K in Q1 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

Commonwealth Equity Services reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
Commonwealth Equity Services sold 1,586 Kite Pharma, Inc. shares in Q4 2017, an estimated $285K.
Commonwealth Equity Services first reported a position in Kite Pharma, Inc. in Q2 2015 and held it in 4 quarters.
Commonwealth Equity Services's Kite Pharma, Inc. position peaked at $333K in Q1 2017.
0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Commonwealth Equity Services's 13F filing for Q4 2017, filed 12 Feb 2018.